Ayrton Drug Manufacturing Ltd Announces Unaudited Earnings Results for the Third Quarter Ended March 31, 2017
Ayrton Drug Manufacturing Ltd. announced unaudited earnings results for the third quarter ended March 31, 2017. For the quarter, the company reported revenue of GHS 27,113,709 against GHS 30,154,595 a year ago. Operating Profit was GHS 4,753,868 against GHS 4,521,633 a year ago. Profit before taxation was GHS 3,814,104 against GHS 2,717,135 a year ago. Profit for the period was GHS 3,120,794 against GHS 2,414,234 a year ago. Earnings per share were GHS 0.0145 against GHS 0.0112 a year ago. Net cash flow from operating activities were GHS 1,234,284 against GHS 1,798,744 a year ago. Cash used in purchase of property, plant and equipment was GHS 817,718 against GHS 475,317 a year ago.